CA
VIVO

Cortland Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

Cortland Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,050,000
Closed -$19.6M – 48
2015
Q2 		$19.6M Buy
+1,050,000
New +$19.5M 0.32% 47

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Cortland Advisers's VIVO Position: Q3 2015 in Review

Cortland Advisers sold out of Meridian Bioscience Inc (VIVO) in Q3 2015, closing a stake of 1,050,000 shares — an estimated $19.6M sold.

Cortland Advisers first reported a position in VIVO in Q2 2015 and held it in 1 quarter. The position peaked at $19.6M in Q2 2015. 175 funds tracked by Wall St. Rank hold VIVO as of Q3 2015.

  • Cortland Advisers reported no remaining Meridian Bioscience Inc position as of Q3 2015 after selling out during the quarter.
  • Cortland Advisers sold 1,050,000 Meridian Bioscience Inc shares in Q3 2015, an estimated $19.6M.
  • Cortland Advisers first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 1 quarter.
  • Cortland Advisers's Meridian Bioscience Inc position peaked at $19.6M in Q2 2015.
  • 175 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2015.

Based on Cortland Advisers's 13F filing for Q3 2015, filed 12 Nov 2015.